Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors
Conclusions: Automated software can detect volumetric breast density changes among women on tamoxifen and AI.
Impact: If declines in volumetric density predict breast cancer outcomes, these measures may be used as interim prognostic indicators. Cancer Epidemiol Biomarkers Prev; 26(6); 930–7. ©2017 AACR.
Source: Cancer Epidemiology Biomarkers and Prevention - Category: Cancer & Oncology Authors: Engmann, N. J., Scott, C. G., Jensen, M. R., Ma, L., Brandt, K. R., Mahmoudzadeh, A. P., Malkov, S., Whaley, D. H., Hruska, C. B., Wu, F. F., Winham, S. J., Miglioretti, D. L., Norman, A. D., Heine, J. J., Shepherd, J., Pankratz, V. S., Vachon, C. M., Ker Tags: Research Articles Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Epidemiology | Mammography | Statistics | Tamoxifen | Women